HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 22 filers reported holding HISTOGENICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | -100.0% | 2,000 | -99.9% | 0.00% | – |
| Q2 2018 | $4,324,000 | -9.1% | 1,729,620 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $4,756,000 | +34.1% | 1,729,620 | 0.0% | 0.00% | – |
| Q4 2017 | $3,546,000 | +3.5% | 1,729,620 | 0.0% | 0.00% | – |
| Q3 2017 | $3,425,000 | +10.0% | 1,729,620 | 0.0% | 0.00% | – |
| Q2 2017 | $3,113,000 | +4.0% | 1,729,620 | 0.0% | 0.00% | – |
| Q1 2017 | $2,992,000 | +3.6% | 1,729,620 | 0.0% | 0.00% | – |
| Q4 2016 | $2,888,000 | -47.2% | 1,729,620 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $5,466,000 | +84.8% | 1,729,620 | 0.0% | 0.00% | – |
| Q2 2016 | $2,958,000 | -32.2% | 1,729,620 | -9.3% | 0.00% | -100.0% |
| Q1 2016 | $4,366,000 | -34.8% | 1,906,720 | -0.4% | 0.00% | 0.0% |
| Q4 2015 | $6,697,000 | -12.3% | 1,913,520 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $7,635,000 | -38.2% | 1,913,520 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $12,361,000 | -35.3% | 1,913,520 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $19,116,000 | -7.3% | 1,913,520 | +2.0% | 0.00% | -33.3% |
| Q4 2014 | $20,629,000 | – | 1,875,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 888,889 | $473,000 | 0.28% |
| Archon Capital Management LLC | 793,090 | $432,000 | 0.17% |
| Sofinnova Investments, Inc. | 2,077,040 | $1,132,000 | 0.10% |
| Third Security, LLC | 2,690,570 | $1,466,000 | 0.10% |
| Perceptive Advisors | 1,203,399 | $656,000 | 0.02% |
| Endurant Capital Management LP | 39,978 | $22,000 | 0.01% |
| Palo Alto Investors LP | 302,922 | $165,000 | 0.01% |
| Virtu Financial LLC | 213,352 | $117,000 | 0.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 296,099 | $161,000 | 0.01% |
| Rossmore Private Capital | 11,236 | $6,000 | 0.00% |